1. Home
  2. BCAB vs HUDI Comparison

BCAB vs HUDI Comparison

Compare BCAB & HUDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • HUDI
  • Stock Information
  • Founded
  • BCAB 2007
  • HUDI 2018
  • Country
  • BCAB United States
  • HUDI China
  • Employees
  • BCAB N/A
  • HUDI N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • HUDI Steel/Iron Ore
  • Sector
  • BCAB Health Care
  • HUDI Industrials
  • Exchange
  • BCAB Nasdaq
  • HUDI Nasdaq
  • Market Cap
  • BCAB 28.6M
  • HUDI 23.2M
  • IPO Year
  • BCAB 2020
  • HUDI 2021
  • Fundamental
  • Price
  • BCAB $0.46
  • HUDI $1.56
  • Analyst Decision
  • BCAB Buy
  • HUDI
  • Analyst Count
  • BCAB 2
  • HUDI 0
  • Target Price
  • BCAB $5.00
  • HUDI N/A
  • AVG Volume (30 Days)
  • BCAB 990.6K
  • HUDI 15.6K
  • Earning Date
  • BCAB 03-25-2025
  • HUDI 02-14-2025
  • Dividend Yield
  • BCAB N/A
  • HUDI N/A
  • EPS Growth
  • BCAB N/A
  • HUDI N/A
  • EPS
  • BCAB N/A
  • HUDI 0.01
  • Revenue
  • BCAB $11,000,000.00
  • HUDI $74,270,429.00
  • Revenue This Year
  • BCAB N/A
  • HUDI N/A
  • Revenue Next Year
  • BCAB N/A
  • HUDI N/A
  • P/E Ratio
  • BCAB N/A
  • HUDI $155.75
  • Revenue Growth
  • BCAB N/A
  • HUDI N/A
  • 52 Week Low
  • BCAB $0.43
  • HUDI $1.47
  • 52 Week High
  • BCAB $4.02
  • HUDI $4.25
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 23.28
  • HUDI 31.96
  • Support Level
  • BCAB $0.46
  • HUDI $1.52
  • Resistance Level
  • BCAB $0.49
  • HUDI $1.60
  • Average True Range (ATR)
  • BCAB 0.04
  • HUDI 0.07
  • MACD
  • BCAB 0.03
  • HUDI -0.01
  • Stochastic Oscillator
  • BCAB 27.98
  • HUDI 0.00

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Products are exported to the United States, Mexico, Thailand, Australia, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

Share on Social Networks: